🇺🇸 FDA
Patent

US 10627409

Therapeutic antibodies against ROR-1 protein and methods for use of same

granted A61KA61K2039/505A61P

Quick answer

US patent 10627409 (Therapeutic antibodies against ROR-1 protein and methods for use of same) held by The Regents of the University of California expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/505, A61P, A61P35/00, A61P35/02